Strategic Partnerships Leverage Verily's already active collaborations with Alphabet, Samsung, Salesforce, UCHealth, and academic institutions to propose integrated precision health solutions that augment clinical research, biomarker development, and enterprise health workflows.

Investment-Fueled Expansion Target buyers and partners in regions or sectors where Verily is expanding, such as Singapore, to offer scalable data platforms and AI-ready health data services that align with local regulatory and public health initiatives.

Public Health Focus Position AI-powered population health and outbreak surveillance capabilities to health systems and governments, highlighting Verily’s strength in turning clinical data into actionable public health insights.

Clinical Research Enablement Highlight the Verily Pre Platform and Verily Me consumer app as channels for accelerating trials, biomarker discovery, and patient engagement, appealing to CROs, biopharma, and life sciences researchers.

Scale Through Data Maturity Offer services to transform disparate clinical and regulatory data into AI-ready, governance-compliant datasets, targeting hospitals and health networks aiming to advance precision medicine initiatives and research capabilities.